ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,152,000 | +45.2% | 23,160 | -7.0% | 0.36% | +33.2% |
| Q3 2021 | $1,482,000 | +25.3% | 24,894 | +43.5% | 0.27% | +33.5% |
| Q2 2021 | $1,183,000 | +8.9% | 17,343 | +10.8% | 0.20% | -6.0% |
| Q1 2021 | $1,086,000 | +28.5% | 15,651 | +42.3% | 0.22% | -25.0% |
| Q4 2020 | $845,000 | +142.1% | 10,998 | +135.9% | 0.29% | +123.3% |
| Q3 2020 | $349,000 | +46.6% | 4,662 | +23.5% | 0.13% | +46.6% |
| Q2 2020 | $238,000 | – | 3,774 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |